Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roh

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Journal of the National Cancer Institute|March 26, 2026
Differences in breast cancer survival across Asian American ethnicities compared with non-Latina White females in Kaiser Permanente Northern CaliforniaMarilyn L Kwan, Lia D'Addario, Catherine Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Racial and Ethnic Disparities in Risk of Cardiovascular Disease in Women Treated for Breast CancerSong Yao, Alexa Zimbalist, Haiyang Sheng, et al.
Breast Cancer Research and Treatment|July 6, 2025
Patient characteristics associated with conventional schedule vs. dose dense chemotherapy in women with stage I-IIIA breast cancerJenna Bhimani, Peng Wang, Grace B Gallagher, et al.
JCO Clinical Cancer Informatics|April 18, 2024
Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast CancerJenna Bhimani, Kelli O'Connell, Isaac J Ergas, et al.
Breast Cancer Research : BCR|June 13, 2024
Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019Jenna Bhimani, Kelli O'Connell, Isaac J Ergas, et al.
JAMA Network Open|July 1, 2026
Breast Cancer Survival in Asian American PatientsScarlett Lin Gomez, Julie Von Behren, Valerie McGuire, et al.
International Journal of Cancer|June 2, 2025
Patient factors and modifications to intended chemotherapy for women with Stages I-IIIA breast cancerJenna Bhimani, Peng Wang, Grace B Gallagher, et al.
Cancer|March 11, 2026
The landscape of chemotherapy modifications among women treated for stage I-IIIA breast cancerJenna Bhimani, Kelli O'Connell, Victoria S Blinder, et al.
Breast Cancer Research and Treatment|August 16, 2024
The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery systemJenna Bhimani, Kelli O'Connell, Sonia Persaud, et al.
JCO Oncology Practice|December 11, 2025
Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast CancerYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Journal of the National Cancer Institute|March 26, 2026
Differences in breast cancer survival across Asian American ethnicities compared with non-Latina White females in Kaiser Permanente Northern CaliforniaMarilyn L Kwan, Lia D'Addario, Catherine Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Racial and Ethnic Disparities in Risk of Cardiovascular Disease in Women Treated for Breast CancerSong Yao, Alexa Zimbalist, Haiyang Sheng, et al.
Breast Cancer Research and Treatment|July 6, 2025
Patient characteristics associated with conventional schedule vs. dose dense chemotherapy in women with stage I-IIIA breast cancerJenna Bhimani, Peng Wang, Grace B Gallagher, et al.
JCO Clinical Cancer Informatics|April 18, 2024
Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast CancerJenna Bhimani, Kelli O'Connell, Isaac J Ergas, et al.
Breast Cancer Research : BCR|June 13, 2024
Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019Jenna Bhimani, Kelli O'Connell, Isaac J Ergas, et al.
JAMA Network Open|July 1, 2026
Breast Cancer Survival in Asian American PatientsScarlett Lin Gomez, Julie Von Behren, Valerie McGuire, et al.
International Journal of Cancer|June 2, 2025
Patient factors and modifications to intended chemotherapy for women with Stages I-IIIA breast cancerJenna Bhimani, Peng Wang, Grace B Gallagher, et al.
Cancer|March 11, 2026
The landscape of chemotherapy modifications among women treated for stage I-IIIA breast cancerJenna Bhimani, Kelli O'Connell, Victoria S Blinder, et al.
Breast Cancer Research and Treatment|August 16, 2024
The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery systemJenna Bhimani, Kelli O'Connell, Sonia Persaud, et al.
JCO Oncology Practice|December 11, 2025
Clinician- and Facility-Level Factors Associated With Receipt of Nonguideline Chemotherapy Regimens in Women With Stage I-IIIA Breast CancerYashasvini Sampathkumar, Ziad Zakaria, Kelli O'Connell, et al.
Pageof 13